Key result
A combined approach involving a clinical questionnaire and diagnostic testing facilitated the early recognition and successful treatment of clozapine-induced myocarditis in a series of 3 cases.
Case Report (n=3)
No
A combined approach using a clinical questionnaire and diagnostic testing may aid in the early recognition and treatment of life-threatening clozapine-induced myocarditis.
Answers are grounded in this paper and cite their sources.
May aid early myocarditis detection during clozapine therapy; leaves open need for prospective validation before routine adoption.
Recently, there has been an increased recognition of the association of clozapine with myocarditis and myocardiopathy. Commonly used diagnostic tests have very limited sensitivity in diagnosing this potentially life-threatening complication. We present 3 case reports of clozapine-induced myocarditis/cardiomyopathy that illustrate the development of a combined approach involving a clinical questionnaire and diagnostic testing at our hospital. This combination approach helped in the early recognition and successful treatment of clozapine myocarditis in one of our patients. Given the increasing recognition of this adverse reaction, we felt it timely to report our experience in diagnosing and treating this clinical syndrome.
No takes yet. Share an insight, caveat, or question.
Annamraju et al. (2007) conducted a case report in Clozapine-induced myocarditis/cardiomyopathy (n=3). Combined approach involving a clinical questionnaire and diagnostic testing was evaluated on Early recognition and successful treatment. A combined approach involving a clinical questionnaire and diagnostic testing facilitated the early recognition and successful treatment of clozapine-induced myocarditis in a series of 3 cases.
Synapse has enriched 10 related papers. Consider them for comparative context: